Biologic agents may satisfy an unmet clinical need for treatment of refractory autoimmune
hepatitis. The goals of this review are to present the types and results of biologic therapy for …

Autoimmune hepatitis (AIH) is a chronic inflammatory disease of the liver, characterized by
elevated transaminase, high circulating immunoglobin G levels, presence of autoantibodies …

Interleukin 2 is essential for the expansion of regulatory T cells, and low-dose recombinant
interleukin 2 has improved the clinical manifestations of diverse autoimmune diseases in …

Autoimmune hepatitis (AIH) is an autoimmune liver disease induced by environmental
factors in genetically susceptible individuals. AIH is characterized by …

The aetiology of vitiligo has not been fully elucidated, and several hypotheses have been
investigated; among them, the most explored assumes an autoimmune basis for the …

Abstract Background & Aims Approximately 5%–10% of the general population respond
inadequately to licensed recombinant hepatitis B vaccines. We assessed the …

Background The prognosis of hepatocellular carcinoma (HCC) is influenced by both tumor
and patient specific factors. Current therapies of advanced HCC target angiogenesis and …

Viral hepatitis is a devastating disease with the risk for cirrhosis and carcinogenicity.
Regulatory T cells (Tregs) play important roles in the disease course of viral hepatitis via …

Henoch-Schönlein purpura nephritis (HSPN) is a common vasculitis that mostly affects
children, and previous studies have indicated that genetic factors may influence disease …

Introduction: An imbalance of the genetically determined cytokine response plays a key role
in the etiology of ENT-associated encephalitis. In recent years, an attempt has been made to …